NEUMORA THERAPEUTICS, INC. (NMRA) Free cash flow 2022–2023
NEUMORA THERAPEUTICS, INC. (NMRA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$163.4MFY2023 · since FY2022: -$115.4M → -$163.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -$163.4M | -41.6% |
| FY2022 | -$115.4M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice